A rapid, non-invasive, cost-effective, analytical device for bacterial or viral infection diagnosis through ultra-high sensitivity breath analysis.

our mission

Antibiotic resistant bacteria cause of more than 25,000 premature deaths in Europe every year.

So far, a global consumption of antibiotics increased by 40% in the last decade has been doing nothing but aggravating the problem. Antibiotics are becoming less effective and the risk for the near future is to become dangerously exposed to infectious diseases.

In this sense, breath analysis is receiving ever increasing attention as it provides a non-invasive clinical test that can be used for early disease detection. In the future, rapid breath diagnostics should be able to allow doctors prescribing the most appropriate available medicine, so to protect our most valuable drugs from over-consumption.

The BreathSpec® project aims to develop a rapid, non-invasive device that can diagnose bacterial or viral infections through ultra-high sensitivity breath analysis.

Call identifier

FTIPilot-01-2016 - Fast Track to Innovation

Duration

27 months

Starting Date

May 1, 2017

Project Number

755667

the project

Objectives

Undertake value engineering and health economics studies to inform the commercialisation process.

Undertake field trials to validate the optimised device with input from key stakeholders including full analytical and clinical validation

To optimise the design and functionality of the existing analytical device for the purpose of breath analysis for microbial volatiles, upgrading sensitivity and selectivity.

To undertake multi-centre studies using healthy volunteers and patients with known pathologies to generate characteristic data for the production of algorithms to separate bacterial from viral infections.

Undertake field trials to validate the optimised device with input from key stakeholders including full analytical and clinical validation